openaccessgovernment1d
New NHS treatment offers hope for children with Lennox–Gastaut syndrome
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
National Institute for Health and Care Excellence2d
New life-changing treatment option recommended to help control seizures for type of rare epilepsy
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
pharmaphorum2d
UCB's non-cannabis drug for severe epilepsy gets NHS okay
The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...
NHS England3d
NHS rolls out life-changing treatment offering ‘new hope’ for hundreds of children with severe epilepsy
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their ...
MONTCO.Today on MSN1d
Plymouth Meeting’s Harmony Biosciences Pivots After FDA Rejects Wakix for Sleep Disorder
Plymouth Meeting’s Harmony Biosciences’ stock fell 10% on Wednesday after the FDA rejected the expansion of its insomnia drug ...
pharmaphorum2d
Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid
Bexicaserin is being developed to treat a group of disorders known as developmental and epileptic encephalopathies (DEEs), including Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis ...
learningdisabilitytoday.co.uk2d
New epilepsy treatment for Lennox–Gastaut syndrome
NICE has approved another epilepsy treatment for Lennox–Gastaut syndrome. Fenfluramine can be used as an add-on to other ...
National Health Executive2d
Groundbreaking new child epilepsy treatment
Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...